Steven Cohen’s Bicara Therapeutics BCAX Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAX
SL
Steven Cohen's BCAX Position: Q3 2026 in Review
Steven Cohen opened a new position in Bicara Therapeutics (BCAX) in Q3 2026: 627,108 shares worth $11.7M. The stake represents 0.01% of the portfolio and ranks #1259 among its holdings. This is a return to the name: Steven Cohen previously reported a position in BCAX as recently as Q3 2025.
Steven Cohen first reported a position in BCAX in Q3 2024 and has held it in 4 quarters since. 167 funds tracked by Wall St. Rank hold BCAX as of Q3 2026.
- Steven Cohen held 627,108 shares of Bicara Therapeutics worth $11.7M as of Q3 2026.
- Bicara Therapeutics was a new Steven Cohen position in Q3 2026.
- Bicara Therapeutics made up 0.01% of Steven Cohen's portfolio in Q3 2026, its #1259 holding.
- Steven Cohen first reported a position in Bicara Therapeutics in Q3 2024 and has held it in 4 quarters since.
- 167 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.